Multi-Drug Test Kit for Surface Residues, Wipe Test and All Liquid and Solid Sample Types

Product Overview

The Instanosis 12-Panel Multi-Drug Test Kit is a premium, comprehensive multi-drug screening assay engineered for forensic, workplace, clinical research, and public health monitoring applications. Manufactured under strict quality controls in the USA, this all-in-one multiplexed assay simultaneously screens for twelve distinct substance classes using standardized, highly accurate analytical cut-offs. This rapid device delivers clear, easily interpretable qualitative results in 5 minutes, providing exceptional specificity and peerless reliability for forensics, harm reduction and public health.

Technical Specifications & Key Data

This multiplexed lateral flow immunoassay device offers broad-spectrum screening capabilities across a comprehensive panel of targeted compound classes:

• Simultaneous 12-Panel Detection Profile With Cross Reactivity for 23 Drugs:

  Drug name	Detect by	Sensitivity
  Fentanyl	FYL	0.002 µg/mL
  Xylazine	XYL	0.01 µg/mL
  4-OH-Xylazine	XYL	0.01 µg/mL
  Isotonitazene	NIT	0.05 µg/mL
  Metonitazene	NIT	0.05 µg/mL
  Methamphetamine	MET	0.05 µg/mL
  Secobarbital	BAR	0.01 µg/mL
  Phenobarbital	BAR	0.01 µg/mL
  Pentobarbital	BAR	0.01 µg/mL
  Amobarbital	BAR	0.01 µg/mL
  Heroin	OPI	0.001 µg/mL
  Oxycodone	OPI	1.0 µg/mL
  Hydrocodone	OPI	0.1 µg/mL
  Hydromorphone	OPI	0.01 µg/mL
  Phencyclidine	PCP	0.05 µg/mL
  Cocaine	COC	0.01 µg/mL
  Amphetamine	AMP	0.05 µg/mL
  Diazepam	BZD	0.05 µg/mL
  Bromazolam	BZD	0.01 µg/mL
  Alprazolam	BZD	0.01 µg/mL
  MDMA	MDMA	0.05 µg/mL
  (-) Δ9 Tetrahydrocannabinol	THC	5.0 µg/mL
  (-) Δ9 Tetrahydrocannabiorcol	THC	0.2 µg/mL

• Rapid Result: Qualitative readouts emerge within 5 minutes.

• Origin & Quality Standards: Proudly Made in the U.S. following stringent quality assurance benchmarks.

Institutional & Clinical Utility

In an era dominated by complex polysubstance trends, multi-panel screening devices provide vital systemic benefits for screening networks:

• Workflow Optimization: Combining twelve individual assays into a single device reduces hands-on procedural processing times by over 90% compared to executing individual single-strip tests.

• Polysubstance Intelligence: Enables occupational health compliance officers, forensic technicians, and clinical researchers to instantly construct a broad forensic toxicological baseline.

Frequently Asked Questions (FAQ)

• Q1: What specific compound classes does this 12-panel test kit detect?

A: This multiplexed kit simultaneously screens for twelve distinct classes: opiates, fentanyl, cocaine, xylazine, nitazenes, PCP, amphetamine, methamphetamine, barbiturates, THC, MDMA, and benzodiazepines.

• Q2: Is this multi-drug test kit manufactured in the United States?

A: Yes. The Instanosis 12-Panel Multi-Drug Test Kit is entirely developed and manufactured in the USA under rigorous quality management baselines to ensure batch-to-batch consistency and high quality.

• Q3: Can different type of samples be utilized for this multi-drug test kit?

A: Yes. Due to the innovative design, samples that can be utilized for the multi-drug test kit include: wipe test swabs, liquids, drug tablets, residues, crystals and powders.

• Q4:Is this product intended for clinical point-of-care patient diagnostics?

A: No. This product is strictly designed, labeled, and distributed for forensic investigations, harm reduction public health surveillance, and laboratory research applications only.

Kit Contents

Kit Applications

Click to download Kit Instruction